{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:37Z","timestamp":1791498277664,"version":"4.3.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.nbd.2023.106067","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T02:08:07Z","timestamp":1678154887000},"page":"106067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["NF-\u03baB\/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients"],"prefix":"10.1016","volume":"180","author":[{"given":"Vanessa","family":"Porrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Lanzillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bonacina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Alberici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Turrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106067_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111385","article-title":"Mitochondria and cellular redox state on the route from ageing to Alzheimer\u2019s disease","volume":"192","author":"Abate","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"12","key":"10.1016\/j.nbd.2023.106067_bb0010","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"issue":"Pt 9","key":"10.1016\/j.nbd.2023.106067_bb0015","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/brain\/aws193","article-title":"Late-onset parkinsonism in NF\u03baB\/c-Rel-deficient mice","volume":"135","author":"Baiguera","year":"2012","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106067_bb0020","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.200809060","article-title":"Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons","volume":"184","author":"Berman","year":"2009","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.nbd.2023.106067_bb0025","first-page":"2656","article-title":"Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase","volume":"61","author":"Bernard","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0030","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-kappa B as a therapeutic target in neurodegenerative diseases","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0040","first-page":"89","article-title":"Immunity and inflammation in neurodegenerative diseases","volume":"2","author":"Cappellano","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2023.106067_bb0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0","article-title":"Oxidative DNA damage in the aging mouse brain","volume":"14","author":"Cardozo-Pelaez","year":"1999","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"10","key":"10.1016\/j.nbd.2023.106067_bb0050","first-page":"2991","article-title":"Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs","volume":"120","author":"Carrasco","year":"1994","journal-title":"Dev. Camb. Engl."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson\u2019s disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0060","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/MCB.20.8.2687-2695.2000","article-title":"The Rel\/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L)","volume":"20","author":"Chen","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0065","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201108059","article-title":"Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential","volume":"195","author":"Chen","year":"2011","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.nbd.2023.106067_bb0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/14737175.2020.1800454","article-title":"Therapeutic innovation in Parkinson\u2019s disease: a 2020 update on disease-modifying approaches","volume":"20","author":"Colombo","year":"2020","journal-title":"Expert. Rev. Neurother."},{"issue":"16","key":"10.1016\/j.nbd.2023.106067_bb0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.nbd.2023.106067_bb0080","series-title":"Studies in Classification, Data Analysis, and Knowledge Organization","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-00032-9_13","article-title":"On two classes of weighted rank correlation measures deriving from the Spearman\u2019s \u03c1","author":"Dancelli","year":"2013"},{"issue":"12","key":"10.1016\/j.nbd.2023.106067_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"7","key":"10.1016\/j.nbd.2023.106067_bb0090","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/mds.29058","article-title":"Can we treat neurodegenerative proteinopathies by enhancing protein degradation?","volume":"37","author":"Engelender","year":"2022","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"11","key":"10.1016\/j.nbd.2023.106067_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.0000000000009107","article-title":"Disease modification and biomarker development in Parkinson disease: revision or reconstruction?","volume":"94","author":"Espay","year":"2020","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0100","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/ard.2009.122887","article-title":"Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population","volume":"69","author":"Eyre","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0105","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.3390\/nu11020345","article-title":"A polyphenol-enriched supplement exerts potent epigenetic-protective activity in a cell-based model of brain ischemia","volume":"11","author":"Faggi","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.nbd.2023.106067_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.05.027","article-title":"SOD2 in mitochondrial dysfunction and neurodegeneration","volume":"62","author":"Flynn","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2023.106067_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.pmbts.2015.08.002","article-title":"Understanding the roles of the NF-\u03baB pathway in regulatory T cell development, differentiation and function","volume":"136","author":"Fulford","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.nbd.2023.106067_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fneur.2019.00232","article-title":"Peripheral-central Neuroimmune crosstalk in Parkinson\u2019s disease: what do patients and animal models tell us?","volume":"10","author":"Fuzzati-Armentero","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2023.106067_bb0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.nbd.2023.106067_bb0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ajpath.2011.11.007","article-title":"The NF-\u03baB subunit c-Rel stimulates cardiac hypertrophy and fibrosis","volume":"180","author":"Gaspar-Pereira","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2023.106067_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson\u2019s disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.nbd.2023.106067_bb0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1947601911421925","article-title":"The c-Rel transcription factor in development and disease","volume":"2","author":"Gilmore","year":"2011","journal-title":"Genes Cancer"},{"issue":"7","key":"10.1016\/j.nbd.2023.106067_bb0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng.395","article-title":"REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis","volume":"41","author":"Gregersen","year":"2009","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3892\/ijmm.2020.4806","article-title":"MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson\u2019s disease: an exploratory study","volume":"47","author":"Grossi","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.nbd.2023.106067_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/j.1753-4887.2012.00476.x","article-title":"Free radicals and antioxidants: updating a personal view","volume":"70","author":"Halliwell","year":"2012","journal-title":"Nutr. Rev."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2012.05.002","article-title":"UCP4 is a target effector of the NF-\u03baB c-Rel prosurvival pathway against oxidative stress","volume":"53","author":"Ho","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"46","key":"10.1016\/j.nbd.2023.106067_bb0165","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.nbd.2023.106067_bb0170","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","article-title":"Total cholesterol and the risk of Parkinson disease","volume":"70","author":"Hu","year":"2008","journal-title":"Neurology."},{"issue":"6 Suppl 3","key":"10.1016\/j.nbd.2023.106067_bb0175","first-page":"S161","article-title":"Oxidative stress and the pathogenesis of Parkinson\u2019s disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0180","first-page":"1373","article-title":"The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis","volume":"38","author":"Jiang","year":"2017","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106067_bb0185","doi-asserted-by":"crossref","DOI":"10.5607\/en.2019.28.5.554","article-title":"Cholesterol metabolism in the brain and its association with Parkinson\u2019s disease","volume":"28","author":"Jin","year":"2019","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.nbd.2023.106067_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.76","article-title":"The acetylation of RelA in Lys310 dictates the NF-\u03baB-dependent response in post-ischemic injury","volume":"1","author":"Lanzillotta","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2023.106067_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.08.018","article-title":"Targeted acetylation of NF-kappaB\/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window","volume":"49","author":"Lanzillotta","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106067_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2015.00098","article-title":"NF-\u03baB in innate neuroprotection and age-related neurodegenerative diseases","volume":"6","author":"Lanzillotta","year":"2015","journal-title":"Front. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2023.106067_bb0210","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","article-title":"Role of the ubiquitin proteasome system in Parkinson\u2019s disease","volume":"8","author":"Lim","year":"2007","journal-title":"BMC Biochem."},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bies.10306","article-title":"Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease","volume":"25","author":"Liou","year":"2003","journal-title":"BioEssays News Rev. Mol. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0220","first-page":"5349","article-title":"Sequential induction of NF-kappa B\/Rel family proteins during B-cell terminal differentiation","volume":"14","author":"Liou","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.nbd.2023.106067_bb0225","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbagen.2019.02.008","article-title":"Monitoring Caco-2 to enterocyte-like cells differentiation by means of electric impedance analysis on printed sensors","volume":"1863","author":"Marziano","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"10","key":"10.1016\/j.nbd.2023.106067_bb0230","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2174\/1570159X19666210203162617","article-title":"Patients stratification strategies to optimize the effectiveness of scavenging biogenic aldehydes: towards a neuroprotective approach for Parkinson\u2019s disease","volume":"19","author":"Masato","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.nbd.2023.106067_bb0235","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of brain aging: adaptive and pathological modification by metabolic states","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2023.106067_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108748","article-title":"The relationship between air pollution and diabetes: a study on the municipalities of the Metropolitan City of Milan","volume":"174","author":"Meroni","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1073858412444007","article-title":"NF-\u03baB signaling pathways: role in nervous system physiology and pathology","volume":"19","author":"Mincheva-Tasheva","year":"2013","journal-title":"Neuroscientist"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2023.106067_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","article-title":"Case-control study of risk of Parkinson\u2019s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan","volume":"293","author":"Miyake","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson\u2019s disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02028-4","article-title":"Neuroprotective epi-drugs quench the inflammatory response and microglial\/macrophage activation in a mouse model of permanent brain ischemia","volume":"17","author":"Mota","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.nbd.2023.106067_bb0265","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/mds.26141","article-title":"Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson\u2019s disease","volume":"30","author":"Murphy","year":"2015","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.nbd.2023.106067_bb0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106067_bb0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-019-0154-z","article-title":"NF-\u03baB\/c-Rel deficiency causes Parkinson\u2019s disease-like prodromal symptoms and progressive pathology in mice","volume":"8","author":"Parrella","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.nbd.2023.106067_bb0280","article-title":"Age-dependent neuropsychiatric symptoms in the NF-\u03baB\/c-Rel knockout mouse model of Parkinson\u2019s disease. Front","volume":"16","author":"Parrella","year":"2022","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2023.106067_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuint.2015.07.025","article-title":"Cholesterol - a putative endogenous contributor towards Parkinson\u2019s disease","volume":"90","author":"Paul","year":"2015","journal-title":"Neurochem. Int."},{"issue":"10","key":"10.1016\/j.nbd.2023.106067_bb0290","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein Misfolding and Neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0295","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson\u2019s disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.nbd.2023.106067_bb0300","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","article-title":"Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease","volume":"90","author":"Pilotto","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106067_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2021.04.016","article-title":"Plasma NfL, clinical subtypes and motor progression in Parkinson\u2019s disease","volume":"87","author":"Pilotto","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2006.06.027","article-title":"Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms","volume":"545","author":"Pizzi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.nbd.2023.106067_bb0315","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M201014200","article-title":"Opposing roles for NF-kappa B\/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta","volume":"277","author":"Pizzi","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.nbd.2023.106067_bb0320","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.cdd.4401598","article-title":"NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity","volume":"12","author":"Pizzi","year":"2005","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.nbd.2023.106067_bb0330","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fnagi.2017.00229","article-title":"Mild inflammatory profile without gliosis in the c-Rel deficient mouse modeling a late-onset parkinsonism","volume":"9","author":"Porrini","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"S1","key":"10.1016\/j.nbd.2023.106067_bb0335","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1002\/mds.22638","article-title":"Inflammation and Parkinson\u2019s disease pathogenesis","volume":"25","author":"Przedborski","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"4","key":"10.1016\/j.nbd.2023.106067_bb0340","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/brb3.55","article-title":"Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction","volume":"2","author":"Ramsden","year":"2012","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.nbd.2023.106067_bb0345","first-page":"2303","article-title":"Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for down syndrome pathogenesis","volume":"43","author":"Salvi","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0350","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2008.05783.x","article-title":"NF-kappaB p50\/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia","volume":"108","author":"Sarnico","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2023.106067_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainres.2012.04.013","article-title":"NF-\u03baB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress","volume":"1476","author":"Sarnico","year":"2012","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.nbd.2023.106067_bb0360","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2023.106067_bb0365","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/jnc.12226","article-title":"Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies","volume":"125","author":"Schildknecht","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2023.106067_bb0370","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1038\/s41598-018-28986-7","article-title":"A monocyte gene expression signature in the early clinical course of Parkinson\u2019s disease","volume":"8","author":"Schlachetzki","year":"2018","journal-title":"Sci. Rep."},{"issue":"Pt 7","key":"10.1016\/j.nbd.2023.106067_bb0375","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson\u2019s disease pathology","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain J. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2023.106067_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.nbd.2023.106067_bb0385","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gut.2008.169052","article-title":"Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling","volume":"58","author":"Trynka","year":"2009","journal-title":"Gut."},{"issue":"2","key":"10.1016\/j.nbd.2023.106067_bb0390","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/STROKEAHA.108.528588","article-title":"Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB\/c-Rel-dependent transcription","volume":"40","author":"Valerio","year":"2009","journal-title":"Stroke."},{"issue":"4","key":"10.1016\/j.nbd.2023.106067_bb0395","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/ard.2010.134593","article-title":"Analysis of the REL polymorphism rs13031237 in autoimmune diseases","volume":"70","author":"Varad\u00e9","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.nbd.2023.106067_bb0400","doi-asserted-by":"crossref","first-page":"585584","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.106067_bb0405","doi-asserted-by":"crossref","first-page":"101427","DOI":"10.1016\/j.redox.2020.101427","article-title":"Pro-survival and anti-inflammatory roles of NF-\u03baB c-Rel in the Parkinson\u2019s disease models","volume":"30","author":"Wang","year":"2020","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.nbd.2023.106067_bb0410","first-page":"3289","article-title":"Constitutive and inducible Rel\/NF-kappa B activities in mouse thymus and spleen","volume":"9","author":"Weih","year":"1994","journal-title":"Oncogene."},{"issue":"4","key":"10.1016\/j.nbd.2023.106067_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009956","article-title":"Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:35:45Z","timestamp":1760852145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":83,"alternative-id":["S0969996123000815"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106067","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NF-\u03baB\/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106067"}}